Myopia and presbyopia are terms that represent dysfunctionality in the eyes. In case of myopia, there is difficulty in viewing distant objects and in case of presbyopia, natural lens loses its flexibility to move its focus between near and far objects. Presbyopia occurs in people aged between 40-50 years. Myopia and presbyopia can be treated by surgeries and medication. Also, these conditions can be corrected with glasses or contact lenses. The prevalence of myopia and presbyopia are rising across the world.
Market Dynamics
Frequents approvals for novel treatment options such as lenses and others is expected to drive market growth. For instance, in October 2018, Carl Zeiss Meditec AG (ZEISS) received the U.S. FDA approval for its ReLEx SMILE, to expand the myopia treatment for the patients with astigmatism. Moreover, in September 2018, STAAR Surgical Company received the U.S. FDA approval (PMA Supplement) for Visian Toric ICL for the correction of myopia with astigmatism. Thus, such increasing approvals have provided opportunity for the manufacturers to introduce novel products in the market, which is contributing to growth of the market.
Key features of the study:
Detailed Segmentation:
Global Myopia And Presbyopia Treatment Market, By Disease Type :
Global Myopia And Presbyopia Treatment Market, By Region:
Company Profiles
“*” marked represents similar segmentation in other categories in the respective section
Market Dynamics
Frequents approvals for novel treatment options such as lenses and others is expected to drive market growth. For instance, in October 2018, Carl Zeiss Meditec AG (ZEISS) received the U.S. FDA approval for its ReLEx SMILE, to expand the myopia treatment for the patients with astigmatism. Moreover, in September 2018, STAAR Surgical Company received the U.S. FDA approval (PMA Supplement) for Visian Toric ICL for the correction of myopia with astigmatism. Thus, such increasing approvals have provided opportunity for the manufacturers to introduce novel products in the market, which is contributing to growth of the market.
Key features of the study:
- This report provides in-depth analysis of the myopia and presbyopia treatment market, market size (US$ Billion) and compound annual growth rate (CAGR (%)) for the forecast period, 2020-2027, considering 2019 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global myopia and presbyopia treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, end user upgrades, market expansion, and marketing tactics
- The global myopia and presbyopia treatment market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for myopia and presbyopia treatment market, research and consulting firms, new entrants, and financial analysts
- Various strategy matrices used in analyzing the myopia and presbyopia treatment market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
Global Myopia And Presbyopia Treatment Market, By Disease Type :
- Myopia
- Presbyopia
- Global Myopia And Presbyopia Treatment Market, By Treatment Type
- Prescription Lenses
- Contact Lenses
- Surgery
- Medication
- Others
Global Myopia And Presbyopia Treatment Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- ALCON Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Bausch Health Companies Inc.
- EssilorLuxottica (Essilor Ltd.)
- Johnson & Johnson Vision
- NIDEK CO. LTD.
- Topcon Corporation
- Zeimer Ophthalmic Systems AG
- ZEISS International
“*” marked represents similar segmentation in other categories in the respective section
Table of Contents
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Myopia And Presbyopia Treatment Market, Impact of COVID-19 Pandemic
5. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2020-2027 (US$ Bn)
6. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2020-2027 (US$ Bn)
7. Global Myopia And Presbyopia Treatment Market, By Region, 2020-2027 (US$ Bn)
8. Competitive Landscape
9. Section
Companies Mentioned
A selection of companies mentioned in this report includes:
- ALCON Inc.
- Bausch Health Companies Inc.
- EssilorLuxottica (Essilor Ltd.)
- Johnson & Johnson Vision
- NIDEK CO. LTD.
- Topcon Corporation
- Zeimer Ophthalmic Systems AG
- ZEISS International
